Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Beilstein J Org Chem ; 20: 661-671, 2024.
Article in English | MEDLINE | ID: mdl-38590540

ABSTRACT

Herein, we report a visible-light-mediated palladium-catalyzed three-component radical-polar crossover carboamination of 1,3-dienes or allenes with diazo esters and amines, affording unsaturated γ- and ε-amino acid derivatives with diverse structures. In this methodology, the diazo compound readily transforms into a hybrid α-ester alkylpalladium radical with the release of dinitrogen. The radical intermediate selectively adds to the double bond of a 1,3-diene or allene, followed by the allylpalladium radical-polar crossover path and selective allylic substitution with the amine substrate, thereby leading to a single unsaturated γ- or ε-amino acid derivative. This approach proceeds under mild and simple reaction conditions and shows high functional group tolerance, especially in the incorporation of various bioactive molecules. The studies on scale-up reactions and diverse derivatizations highlight the practical utility of this multicomponent reaction protocol.

2.
J Biol Chem ; 290(29): 18102-18110, 2015 Jul 17.
Article in English | MEDLINE | ID: mdl-26055714

ABSTRACT

One of the fundamental functions of molecular chaperone proteins is to selectively conjugate cellular proteins, targeting them directly to lysosome. Some of chaperones, such as the stress-induced Hsp70, also play important roles in autophagosome-forming macroautophagy under various stress conditions. However, the role of their co-chaperones in autophagy regulation has not been well defined. We here show that Tid1, a DnaJ co-chaperone for Hsp70 and the mammalian homologue of the Drosophila tumor suppressor Tid56, is a key mediator of macroautophagy pathway. Ectopic expression of Tid1 induces autophagy by forming LC3+ autophagosome foci, whereas silencing Tid1 leads to drastic impairment of autophagy as induced by nutrient deprivation or rapamycin. In contrast, Hsp70 is dispensable for a role in nutrient deprivation-induced autophagy. The murine Tid1 can be replaced with human Tid1 in murine fibroblast cells for induction of autophagy. We further show that Tid1 increases autophagy flux by interacting with the Beclin1-PI3 kinase class III protein complex in response to autophagy inducing signal and that Tid1 is an essential mediator that connects IκB kinases to the Beclin1-containing autophagy protein complex. Together, these results reveal a crucial role of Tid1 as an evolutionarily conserved and essential mediator of canonical macroautophagy.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Autophagy , HSP40 Heat-Shock Proteins/metabolism , Membrane Proteins/metabolism , Animals , Beclin-1 , Cell Line , Drosophila/metabolism , Drosophila Proteins/metabolism , HSP70 Heat-Shock Proteins/metabolism , Heat-Shock Proteins/metabolism , Humans , I-kappa B Kinase/metabolism , Mice , Mitochondrial Proteins , Protein Interaction Maps
3.
PLoS One ; 8(8): e73261, 2013.
Article in English | MEDLINE | ID: mdl-24015299

ABSTRACT

Anti-HER2/neu antibody therapy has been reported to mediate tumor regression of HER2/ neu(+) tumors. Here we demonstrated the expression of HER2 in a wide range of human melanoma cells including a primary culture and seven cell lines, and we further investigated whether HER2 could be served as a target for T cell mediated immunotherapy of human melanoma. Specific cytolytic activity of activated T cells (ATC) armed with anti-CD3 x anti-HER2 bispecific antibody (HER2Bi-Ab) against Malme-3M-luc cells was evaluated by bioluminescent signal generated by luciferase reporter which did not alter HER2 expression or proliferation ability of Malme-3M cells. Contrast with unarmed ATC, increased cytotoxic activity of HER2Bi-armed ATC against Malme-3M-luc cells was observed at effector/target (E/T) ratios of 1:1, 5:1, and 20:1. Moreover, HER2Bi-armed ATC expressed higher level of activation marker CD69 and secreted significantly higher level of IFN-γ than unarmed ATC counterpart at the E/T ratio of 20:1. In addition, compared with anti-HER2 mAb (Herceptin®) or unarmed ATC, HER2Bi-armed ATC showed remarkable suppression effect on Malme-3M-luc tumor cells. Furthermore, in melanoma tumor cell xenograft mice, infusion of HER2Bi-armed ATC successfully inhibited the growth of melanoma tumors. The anti-tumor effect of HER2Bi-armed ATC may provide a promising immunotherapy for melanoma in the future.


Subject(s)
Antibodies, Bispecific/pharmacology , Antibodies, Neoplasm/pharmacology , CD3 Complex/immunology , Lymphocyte Activation/drug effects , Melanoma/drug therapy , Receptor, ErbB-2/immunology , T-Lymphocytes/immunology , Animals , Antibodies, Bispecific/immunology , Antibodies, Neoplasm/immunology , CD3 Complex/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Enzymologic/immunology , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/immunology , Humans , K562 Cells , Lymphocyte Activation/immunology , Melanoma/immunology , Melanoma/pathology , Mice , Mice, SCID , Receptor, ErbB-2/genetics , Receptor, ErbB-2/metabolism , T-Lymphocytes/pathology , Xenograft Model Antitumor Assays
4.
FEBS Lett ; 587(18): 2958-64, 2013 Sep 17.
Article in English | MEDLINE | ID: mdl-23954298

ABSTRACT

Enteropeptidase can cleave trypsinogen on the sequence of Asp-Asp-Asp-Asp-Lys and plays an important role in food digestion. The RANKL-RANK signalling pathway plays a pivotal role in bone remodelling. In this study, we reported that enteropeptidase can inhibit the RANKL-RANK signalling pathway through the cleavage of RANK. A surrogate peptide blocking assay indicated that enteropeptidase could specifically cleave RANK on the sequence NEEDK. Osteoclast differentiation assay and NF-κB activity assay confirmed that enteropeptidase could inhibit osteoclastogenesis in vitro through the cleavage of RANK. This is the first study to prove that the RANKL-RANK signalling pathway can be inhibited by cleavage of RANK instead of targeting RANKL.


Subject(s)
Bone and Bones/enzymology , Enteropeptidase/antagonists & inhibitors , Macrophages/enzymology , Osteoclasts/enzymology , Peptides/pharmacology , RANK Ligand/metabolism , Receptor Activator of Nuclear Factor-kappa B/metabolism , Amino Acid Motifs , Animals , Binding Sites , Bone and Bones/cytology , Bone and Bones/drug effects , Cell Differentiation , Cell Line , Enteropeptidase/genetics , Enteropeptidase/metabolism , Gene Expression Regulation , Macrophages/cytology , Macrophages/drug effects , Mice , Molecular Sequence Data , Osteoclasts/cytology , Osteoclasts/drug effects , Peptides/chemical synthesis , Protein Binding , Protein Interaction Domains and Motifs , Proteolysis , RANK Ligand/genetics , Receptor Activator of Nuclear Factor-kappa B/genetics , Sequence Homology, Amino Acid , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...